A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease
Clinical trial NCT05496374 · COMPLETED
Trial details
- NCT number
- NCT05496374
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-14
- Primary completion
- 2024-10-08
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.